Previous Article | Next Article 
Journal of Clinical Microbiology, November 1999, p. 3756-3758, Vol. 37, No. 11
Department of Pathology and
Microbiology1 and Department of
Healthcare Epidemiology,2 University of
Nebraska Medical Center, Omaha, Nebraska, and Department of
Pathology, University of Illinois at Chicago, Chicago,
Illinois3
Received 3 May 1999/Returned for modification 22 June 1999/Accepted 19 July 1999
The revised MicroScan Dried Overnight Gram-Positive Identification
panel was evaluated for its efficacy at identifying
Enterococcus species in comparison with conventional
biochemical tests. Supplemental testing of ampicillin-susceptible
Enterococcus faecium for motility and the ability to
acidify methyl- The enterococci have emerged as the
third most common cause of nosocomial bacteremia (14, 16,
27). This increase in infections is due in part to an escalation
of resistance to antimicrobial therapy, including high-level resistance
to aminoglycosides and vancomycin (3, 9, 13, 23, 28).
Resistance is most frequently associated with Enterococcus
faecium, even though other species conferring resistance are
appearing (3, 15, 22, 28). The treatment of infections
caused by high-level vancomycin-resistant enterococci is difficult,
making it important to recognize these species. Additionally,
infections caused by enterococci with intrinsic low-level vancomycin
resistance have been shown to cause failure of vancomycin therapy
(10, 20). Enterococcus faecalis and E. faecium account for 80 to 90% and 10 to 15% of enterococcal infections, respectively, and other species including E. gallinarum, E. casseliflavus, E. raffinosus,
E. durans, E. hirae, and E. avium, account for a majority of the remainder (14-17,
19). Identification systems, such as Vitek and MicroScan, have
been utilized to identify only a few of the Enterococcus
species, including E. faecalis, E. faecium,
E. durans, and E. avium (1, 4, 24).
Recently, MicroScan revised the gram-positive identification panel by
adding Enterococcus species (E. casseliflavus,
E. gallinarum, and E. raffinosus and combining
E. hirae with E. durans as E. durans/hirae) to the database, reformulating biochemical tests,
and including new tests. The purpose of this study was to evaluate the
revised Dried Overnight Gram-Positive Identification (CPID2) panel for the ability to accurately identify Enterococcus species.
(This work was presented in part at the 98th General Meeting of the
American Society for Microbiology, Atlanta, Ga., 17 to 21 May 1998.)
The Enterococcus species evaluated included 133 stock and 69 fresh isolates (60 E. faecalis [all vancomycin
susceptible] isolates, 59 E. gallinarum isolates, 30 E. casseliflavus isolates, 27 E. faecium [7
vancomycin resistant] isolates, 9 E. raffinosus isolates, 8 E. durans isolates, 6 E. hirae isolates, and 3 E. avium isolates). Only one isolate per patient was tested.
The stock isolates had been stored frozen at The revised CPID2 test panels were obtained from the manufacturer
(Dade MicroScan, Inc., West Sacramento, Calif.) and inoculated with a turbidity equivalent to that of a 0.5 McFarland standard. The
panels were incubated 18 to 20 h at 35°C in ambient air and read
manually according to the manufacturer's recommendations. The
panels were tested with the following quality control (QC) strains on a
weekly basis throughout the study period:
Staphylococcus aureus ATCC 29213, E. faecalis
ATCC 29212, Streptococcus bovis ATCC 49147, Micrococcus luteus ATCC 49732, Staphylococcus
saprophyticus ATCC 49907, Staphylococcus xylosus ATCC
49148, Streptococcus pneumoniae ATCC 49136, and E. avium ATCC 49464. QC testing was within normal limits.
The abbreviated conventional biochemical identification scheme of
Facklam and Collins (11) was used as a basis for species identification with modifications as outlined in a previous study (13). The reagent for acidification of 1%
methyl- The biotype number was generated by giving a weighted numerical
value to all positive reactions. This biotype number was submitted to
MicroScan and evaluated by using a BATCHID identification program to generate an identification. Once an identification was determined, it was compared with the results of conventional biochemical testing. No additional testing was done if the CPID2 test panel result was a
high-probability species identification (>85%) and it matched the
conventional biochemical testing result. If the panel result was a
low-probability identification (<85%) and listed multiple possible
species, one of which matched the result by conventional testing,
additional biochemical tests as indicated on the MicroScan printout
were evaluated (e.g., motility test and evaluation for colony
pigmentation). Isolates exhibiting a discrepancy between the test panel
and conventional biochemical testing were repeat tested with the CPID2
test panel. Biochemical assays were considered the reference standard
for all discrepant results.
The initial accuracies of the revised CPID2 test panel for
Enterococcus species were 100% for E. faecium
(27 of 27), E. casseliflavus (30 of 30), E. durans (8 of 8), E. hirae (6 of 6), and E. durans (8 of 8), but 98.3% for E. faecalis (59 of 60),
88.9% for E. raffinosus (8 of 9), 66.7% for E. avium (2 of 3), and 40.7% for E. gallinarum (24 of 59)
(Table 1). The single misidentified
E. faecalis isolate was identified as E. avium,
the E. avium isolate was identified as E. raffinosus (88.6%), the E. raffinosus isolate was
identified as a very rare biotype (VRB), and 33 of the E. gallinarum isolates were identified as E. faecium with
2 VRBs. Both of these VRBs were retested with the revised
MicroScan panel, and both were subsequently identified as
E. faecium.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evaluation of the Revised MicroScan Dried Overnight Gram-Positive
Identification Panel To Identify Enterococcus
Species
ABSTRACT
Top
Abstract
Text
References
-D-glucopyranoside helped recognize E. gallinarum and increased the accuracy of the panel for
identifying Enterococcus species to 98.5%.
TEXT
Top
Abstract
Text
References
70°C and prior to
testing were passed twice on sheep blood agar.
-D-glucopyranoside (MGP) was prepared and
evaluated by the procedure of Devriese et al. (8).
TABLE 1.
MicroScan Dried Overnight Gram-Positive Identification
test panel results compared with conventional biochemicals to
identify Enterococcus species
Supplemental tests for motility and the ability to acidify MGP were performed with all isolates identified as E. gallinarum and E. faecium. All E. gallinarum isolates, including those incorrectly identified as E. faecium, were positive by the MGP test, and 54 of 59 (91.5%) were positive for motility. All known E. faecium isolates were negative by both tests. Following this resolution testing, the CPID2 test panel correctly identify 98.5% of the Enterococcus isolates.
In the present study, the overall accuracy of the CPID2 test panel was initially 81.2% (164 of 202). One isolate each of E. faecalis, E. raffinosus, and E. avium was misidentified, and 35 of the 59 isolates of E. gallinarum were incorrect. All misidentified E. gallinarum isolates were recognized as E. faecium (33 from initial testing and 2 upon repeat testing). This inability to distinguish these two closely related species by using automated tests has been reported by others (5, 7, 8, 11, 17, 25). Since supplemental testing with motility and MGP tests has shown reliability to distinguish these species, these tests were applied to all isolates identified by the CPID2 panel as E. gallinarum and E. faecium (2, 7, 8, 12, 25). All of the E. gallinarum isolates were positive for acidification of MGP, and 91.5% were positive for motility, while none of the E. faecium isolates were positive by either test. Unfortunately, this approach would require supplemental testing of all isolates identified by the panel as E. faecium. An alternative approach would be to only test those E. faecium isolates recognized as ampicillin susceptible. Studies have shown that ampicillin resistance is common for E. faecium (>80%), but uncommon for E. gallinarum (<10%) (14, 21). None of the E. gallinarum isolates in this study showed resistance to ampicillin, while 33 of the misidentified E. gallinarum isolates showed intermediate susceptibility (31 isolates) or resistance (2 isolates) to vancomycin. These findings suggest that isolates identified by the CPID2 test panel as E. faecium, which are susceptible to ampicillin and/or intermediate or resistant to vancomycin, should be screened by motility and MGP tests to rule out or identify E. gallinarum.
Finally, a potential shortcoming of the revised MicroScan panel includes the identification of phenotypically atypical enterococcal isolates, especially the nonmotile E. gallinarum and nonmotile and nonpigmented E. casseliflavus isolates. These isolates are rarely encountered in clinical samples, although extensive screens to detect these isolates have not been done (2, 6, 8). Inulin fermentation may be an alternative way to distinguish these species, since in our study, 29 of 30 E. casseliflavus isolates were positive, while only 1 of 59 E. gallinarum isolates was positive. The inulin-negative E. casseliflavus isolate was motile and had an intense yellow colony, while the inulin-positive E. gallinarum isolate was motile and nonpigmented. The latter isolate may in fact be E. casseliflavus, which would require molecular testing for verification (6, 18, 26).
In conclusion, the results of this study showed that the CPID2 test panel was a reliable method for the overnight identification of Enterococcus species; however, supplemental testing is frequently needed to differentiate E. gallinarum from E. faecium.
| |
ACKNOWLEDGMENTS |
|---|
We thank personnel at Dade International, MicroScan Division, for technical support and for reagents and panels necessary to conduct this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pathology and Microbiology, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha, NE 68198-6495. Phone: (402) 559-7774. Fax: (402) 559-4077. E-mail: piwen{at}unmc.edu.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. |
Bascomb, S., and M. Manafi.
1998.
Use of enzyme tests in characterization and identification of aerobic and facultatively anaerobic gram-positive cocci.
Clin. Microbiol. Rev.
11:318-340 |
| 2. | Cartwright, C. P., F. Stock, G. A. Fahle, and V. J. Gill. 1995. Comparison of pigment production and motility tests with PCR for reliable identification of intrinsically vancomycin-resistant enterococci. J. Clin. Microbiol. 33:1931-1933[Abstract]. |
| 3. |
Cercenado, E.,
S. Unal,
C. T. Eliopoulos,
L. G. Rubin,
H. D. Isenberg,
R. C. Moellering, Jr., and G. M. Eliopoulos.
1995.
Characterization of vancomycin resistance in Enterococcus durans.
J. Antimicrob. Chemother.
36:821-825 |
| 4. |
Chen, Y.-S.,
S. A. Marshall,
P. L. Winokur,
S. L. Coffman,
W. W. Wilke,
P. R. Murray,
C. A. Spiegel,
M. A. Pfaller,
G. V. Doern, and R. N. Jones.
1998.
Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci.
J. Clin. Microbiol.
36:2996-3001 |
| 5. | Cheng, S., F. K. McCleskey, M. J. Gress, J. M. Petroziello, R. Liu, H. Namdari, K. Beninga, A. Salmen, and V. G. DelVecchio. 1997. PCR assay for identification of Enterococcus faecium. J. Clin. Microbiol. 35:1248-1250[Abstract]. |
| 6. |
Clark, N. C.,
L. M. Teixeira,
R. R. Facklam, and F. C. Tenover.
1998.
Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci.
J. Clin. Microbiol.
36:2294-2297 |
| 7. |
Da Gloria, M.,
S. Carvalho,
L. M. Teixeira, and R. R. Facklam.
1998.
Use of tests for acidification of methyl--D-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera.
J. Clin. Microbiol.
36:1584-1587 |
| 8. |
Devriese, L. A.,
B. Pot,
K. Kersters,
S. Lauwers, and F. Haesebrouck.
1996.
Acidification of methyl--D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis.
J. Clin. Microbiol.
34:2607-2608[Abstract].
|
| 9. | Eliopoulos, G. M. 1997. Vancomycin-resistant enterococci. Mechanism and clinical relevance. Infect. Dis. Clin. N. Am. 11:851-865[Medline]. |
| 10. |
Endtz, H. P.,
N. van den Braak,
A. van Belkum,
W. H. Goessens,
D. Kreft,
A. B. Stroebel, and H. A. Verbrugh.
1998.
Comparison of eight methods to detect vancomycin resistance in enterococci.
J. Clin. Microbiol.
36:592-594 |
| 11. |
Facklam, R. R., and M. D. Collins.
1989.
Identification of Enterococcus species isolated from human infections by a conventional test scheme.
J. Clin. Microbiol.
27:731-734 |
| 12. |
Hanson, K. L., and C. P. Cartwright.
1999.
Comparison of simple and rapid methods for identifying enterococci intrinsically resistant to vancomycin.
J. Clin. Microbiol.
37:815-817 |
| 13. | Iwen, P. C., D. M. Kelly, J. Linder, and S. H. Hinrichs. 1996. Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J. Clin. Microbiol. 34:1779-1783[Abstract]. |
| 14. | Iwen, P. C., D. M. Kelly, J. Linder, S. H. Hinrichs, E. A. Dominguez, M. E. Rupp, and K. D. Patil. 1997. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob. Agents Chemother. 41:494-495[Medline]. (Letter.) |
| 15. | Morrison, D., N. Woodford, and B. Cookson. 1997. Enterococci as emerging pathogens of humans. Soc. Appl. Bacteriol. Symp. Ser. 26:89s-99s. |
| 16. |
Murray, B. E.
1990.
The life and times of the enterococcus.
Clin. Microbiol. Rev.
3:46-65 |
| 17. |
Patel, R.,
K. E. Piper,
M. S. Rouse,
J. M. Steckelberg,
J. R. Uhl,
P. Kohner,
M. K. Hopkins,
F. R. Cockerill III, and B. C. Kline.
1998.
Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates.
J. Clin. Microbiol.
36:3399-3407 |
| 18. | Patel, R., J. R. Uhl, P. Kohner, M. K. Hopkins, and F. R. Cockerill, III. 1997. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J. Clin. Microbiol. 35:703-707[Abstract]. |
| 19. | Perez Castrillon, J. L., M. Martin Luquero, J. C. Martin Escudero, P. Pascual, A. Casero, and V. Herreros. 1997. Endocarditis caused by Enterococcus avium. Scand. J. Infect. Dis. 29:530[Medline]. |
| 20. | Ratanasuwan, W., P. C. Iwen, S. H. Hinrichs, and M. E. Rupp. 1999. Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin. Infect. Dis. 28:1175-1177[Medline]. |
| 21. | Sahm, D. F., M. L. Hickey, M. K. Marsilio, B. H. Heller, K. M. Tomfohrde, M. E. Jones, and C. Thornsberry. 1998. The importance of species identification in tracking antimicrobial resistance among enterococci, abstr. C-363, p. 191. In Abstracts of the 98th General Meeting of the American Society for Microbiology 1998. American Society for Microbiology, Washington, D.C |
| 22. | Straut, M., G. de Cespédès, and T. Horaud. 1996. Plasmid-borne high-level resistance to gentamicin in Enterococcus hirae, Enterococcus avium, and Enterococcus raffinosus. Antimicrob. Agents Chemother. 40:1263-1265[Abstract]. |
| 23. | Toye, B., J. Shymanski, M. Bobrowska, W. Woods, and K. Ramotar. 1997. Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J. Clin. Microbiol. 35:3166-3170[Abstract]. |
| 24. |
Tritz, D. M.,
P. C. Iwen, and G. L. Woods.
1990.
Evaluation of MicroScan for identification of Enterococcus species.
J. Clin. Microbiol.
28:1477-1478 |
| 25. |
Turenne, C. Y.,
D. J. Hoban,
J. A. Karlowsky,
G. G. Zhanel, and A. M. Kabani.
1998.
Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl--D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faecium.
J. Clin. Microbiol.
36:2333-2335 |
| 26. | Tyrrell, G. J., R. N. Bethune, B. Willey, and D. E. Low. 1997. Species identification of enterococci via intergenic ribosomal PCR. J. Clin. Microbiol. 35:1054-1060[Abstract]. |
| 27. | Wade, J. J. 1997. Enterococcus faecium in hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 16:113-119[Medline]. |
| 28. | Wilke, W. W., S. A. Marshall, S. L. Coffman, M. A. Pfaller, M. B. Edmund, R. P. Wenzel, and R. N. Jones. 1997. Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. Diagn. Microbiol. Infect. Dis. 29:43-49[Medline]. |
Journal of Clinical Microbiology, November 1999, p. 3756-3758, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tsai, J.-C., Hsueh, P.-R., Lin, H.-M., Chang, H.-J., Ho, S.-W., Teng, L.-J.
(2005). Identification of Clinically Relevant Enterococcus Species by Direct Sequencing of groES and Spacer Region. J. Clin. Microbiol.
43: 235-241
[Abstract] [Full Text] -
Teng, L.-J., Hsueh, P.-R., Wang, Y.-H., Lin, H.-M., Luh, K.-T., Ho, S.-W.
(2001). Determination of Enterococcus faecalis groESL Full-Length Sequence and Application for Species Identification. J. Clin. Microbiol.
39: 3326-3331
[Abstract] [Full Text] -
Angeletti, S., Lorino, G., Gherardi, G., Battistoni, F., De Cesaris, M., Dicuonzo, G.
(2001). Routine Molecular Identification of Enterococci by Gene-Specific PCR and 16S Ribosomal DNA Sequencing. J. Clin. Microbiol.
39: 794-797
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»